Ar­row hits Am­neal tar­get

Pharmacy Daily - - NEWS -

AR­ROW Phar­ma­ceu­ti­cals Pty Ltd has an­nounced the com­ple­tion of its ac­qui­si­tion of the Aus­tralian re­tail phar­macy busi­ness of US gener­ics firm Am­neal Phar­ma­ceu­ti­cals, with the deal said to ce­ment Ar­row as “Aus­tralia’s fastest grow­ing generic phar­ma­ceu­ti­cal com­pany” (W break­ing news Fri).

Ar­row chair­man Dennis Bas­tas said the ac­qui­si­tion ex­panded the com­pany’s foot­print and added some “lead­ing prod­ucts and ser­vices” to Ar­row’s port­fo­lio.

“We have been for­tu­nate to have ex­pe­ri­enced strong or­ganic growth across our pri­mary cus­tomer base within both our generic pre­scrip­tion medicines and Chemists’ Own port­fo­lio.

“Bring­ing Am­neal’s cus­tomer base into our net­work of sup­port­ing phar­ma­cies fur­ther ac­cel­er­ates this cur­rent growth and strength­ens the of­fer­ing we bring to all our cus­tomers,” Bas­tas said.

Am­neal Phar­ma­ceu­ti­cals Aus­tralia ceo Gavin Upiter said the Ar­row ac­qui­si­tion would bring a broader range of prod­ucts to the com­pany’s ex­ist­ing cus­tomers and al­low Ar­row to de­liver new ser­vices to its cur­rent ex­ten­sive user base.

Am­neal Phar­ma­ceu­ti­cals com­menced op­er­a­tions in Aus­tralia in 2014 and es­tab­lished a com­pre­hen­sive prod­uct of­fer­ing be­fore ac­quir­ing the Aus­tralian Ac­tavis busi­ness in 2015.

Its as­sets in­clude generic pre­scrip­tion medicines and branded OTC prod­ucts. “Am­neal has a loyal cus­tomer base sup­ported by our di­verse generic phar­ma­ceu­ti­cal range and our in­no­va­tive value so­lu­tions,” Upiter said.

“The Ar­row ac­qui­si­tion will bring a broader range of prod­ucts to our ex­ist­ing cus­tomers and al­low Ar­row to de­liver new ser­vices to its cur­rent ex­ten­sive cus­tomer base.”

He said cur­rent Am­neal cus­tomers would not see any dis­rup­tion, with both groups of cus­tomers to be of­fered a more com­pre­hen­sive prod­uct and ser­vice of­fer­ing.

Newspapers in English

Newspapers from Australia

© PressReader. All rights reserved.